SuperworthCeribell price to book ratio CBLL
Market value divided by the book value of the company's net assets, since 2025.
- Today, Oct 23, 2026
- 8.1×
- Peer median
- 3.4×
Ceribell's price to book ratio is 8.1× as of Oct 23, 2026.
The median for 5 medical device stocks of a similar size is 3.4×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 8.1× | 4.3× | 8.1× |
| 2025 | 4.8× | 2.4× | 4.8× |
Against its peers
Companies in Medical - Devices nearest Ceribell's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| CBLLCeribell | 8.1× |
| CNMDCONMED | 1.4× |
| TMDXTransMedics | 4.7× |
| ITGRInteger | 2.5× |
| LIVNLivaNova | 3.4× |
| ELMDElectromed | 4.1× |
| Peer median | 3.4× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Ceribell
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.